A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
about
Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesisStructural determinants and mechanism of HIV-1 genome packagingEfficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signalLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinPosition dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivoThe human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structuresIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?Cross- and Co-Packaging of Retroviral RNAs and Their ConsequencesThe Life-Cycle of the HIV-1 Gag-RNA ComplexIdentification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitroThe bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag geneInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.The bovine leukemia virus encapsidation signal is composed of RNA secondary structures.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.Quantitative interferometric reflectance imaging for the detection and measurement of biological nanoparticlesHuman immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidationThe leader of the HIV-1 RNA genome forms a compactly folded tertiary structureSequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.Dimerization of human immunodeficiency virus (type 1) RNA: stimulation by cations and possible mechanism.RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cellThe human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure.A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcriptionA conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replicationMutations in the kissing-loop hairpin of human immunodeficiency virus type 1 reduce viral infectivity as well as genomic RNA packaging and dimerization.Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2.Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidationMultiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop.A role for two hairpin structures as a core RNA encapsidation signal in murine leukemia virus virions.Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant virusesPhenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate.
P2860
Q24498694-F22DBDDE-5EB6-4F64-9274-9C924B36756AQ24632055-F6BF15DE-993F-4232-8E97-260C8CA6257EQ24645635-8BA1828F-2DB3-4BB3-AF42-C386259751B5Q24645706-76369948-D639-4559-BCFD-102AC8B1C370Q24678656-C412E753-DD57-48FA-9D11-F0ACC3710A19Q24682817-E29D3338-5004-4E72-B785-24802A397D44Q24805927-1C3B32C2-4BF5-493E-A1A4-97AA57FD097EQ28066817-BC6DB007-AC1B-41C6-AFD5-4399B18BABD9Q28076985-E772296A-EEA0-47A1-87F5-9035DACA86D1Q28254442-7E41F4E6-6B5F-49E6-84D6-005AF08563A3Q28301200-0D604F04-75C8-4203-8EC6-6C9C00636026Q33643700-C67E708F-5465-401E-AE6A-661A1731047CQ33783331-A4087C0D-AB91-4BC9-8B98-BBAF65992B85Q33785662-6C1ED58C-FB00-4470-AC45-DA4E6018EAE7Q33800960-9F7A5FAD-2D2E-4617-A99E-42A9D4E7CFF4Q33816167-7DEDC1F6-6426-47E1-9A40-7845CFE2D40CQ33824480-2699E397-D7BB-4C3B-8204-DD6E43E080BEQ33854807-5DCB56C4-58A1-4ECD-B3BA-9C14EA32F9E8Q34362436-F21C6265-8886-4C2C-89E0-2EF8A9EEF978Q34363543-3D6ABFDB-CA06-46C1-9924-86130E4996E7Q34434755-A4279DA5-E808-4F5F-92D4-5423EE35C3EDQ34673247-F520F3AB-DA81-46EC-BFD9-C702588582FAQ34800316-BDF86619-5DB6-451B-97E9-71EBF975E1AEQ35478282-4132C3F5-1003-48D2-9C77-91288E1379D2Q35804618-410821FD-CE71-433D-B51E-DD66BA9B593AQ35837228-866DD19F-1172-4FAB-805F-53157A8AB8CAQ35840793-AD3F7B6A-97D7-4801-9FCB-9AF5704088A6Q35854559-21E1BDF6-A624-4216-9E42-E467FEA71B2EQ35862080-FF6D5B15-2150-4066-9978-254202915952Q35879394-AA94B3D9-DE61-45C9-BCD7-DB058D201ED8Q35882188-92425433-B220-4CDB-94EA-5BA321F097BBQ35884455-CEBF9187-92E6-46DC-A5F0-942ECD07835CQ35890003-0E545807-BE6F-40EB-B4AF-647FE3539E4BQ35891833-5BB1B10E-82A1-4B37-B4AD-F171107A2DD3Q35895758-3D2411E5-4B5A-4F65-A522-EB175139AA9BQ35896534-6EFBA643-C106-401B-B73B-296026001C68Q35943050-65E2626E-11E5-4301-BEB9-0DCE171DA1FCQ35943592-C2542088-DAD8-498F-9B80-CF45962C29BFQ36619015-5C439AEE-F90A-4C94-8619-AD024C2B331AQ36629169-D07BF466-09E6-4A1F-AEA9-2C948BCFE95A
P2860
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
A mutant of human immunodefici ...... abnormal particle morphology.
@en
type
label
A mutant of human immunodefici ...... abnormal particle morphology.
@en
prefLabel
A mutant of human immunodefici ...... abnormal particle morphology.
@en
P2860
P1433
P1476
A mutant of human immunodefici ...... abnormal particle morphology.
@en
P2093
Orenstein JM
P2860
P304
P407
P577
1990-10-01T00:00:00Z